BR112014005773A2 - composições derivadas de hyr1 e métodos of tratamento usando as mesmas - Google Patents
composições derivadas de hyr1 e métodos of tratamento usando as mesmasInfo
- Publication number
- BR112014005773A2 BR112014005773A2 BR112014005773-7A BR112014005773A BR112014005773A2 BR 112014005773 A2 BR112014005773 A2 BR 112014005773A2 BR 112014005773 A BR112014005773 A BR 112014005773A BR 112014005773 A2 BR112014005773 A2 BR 112014005773A2
- Authority
- BR
- Brazil
- Prior art keywords
- hyr1
- treatment
- methods
- derived compositions
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161534734P | 2011-09-14 | 2011-09-14 | |
| US61/534,734 | 2011-09-14 | ||
| US201161564201P | 2011-11-28 | 2011-11-28 | |
| US61/564,201 | 2011-11-28 | ||
| PCT/US2012/055604 WO2013040478A2 (en) | 2011-09-14 | 2012-09-14 | Hyr1-derived compositions and methods of treatment using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014005773A2 true BR112014005773A2 (pt) | 2019-09-24 |
Family
ID=47884005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014005773-7A BR112014005773A2 (pt) | 2011-09-14 | 2012-09-14 | composições derivadas de hyr1 e métodos of tratamento usando as mesmas |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10160790B2 (enExample) |
| EP (1) | EP2755668A4 (enExample) |
| JP (1) | JP2014527084A (enExample) |
| CN (1) | CN103998049A (enExample) |
| AU (1) | AU2012308281A1 (enExample) |
| BR (1) | BR112014005773A2 (enExample) |
| CA (1) | CA2848403A1 (enExample) |
| EA (1) | EA025831B1 (enExample) |
| GE (2) | GEP20197052B (enExample) |
| UA (1) | UA115305C2 (enExample) |
| WO (1) | WO2013040478A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| US10130691B2 (en) | 2013-03-15 | 2018-11-20 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
| EP2942389A1 (en) * | 2014-05-05 | 2015-11-11 | Servicio Andaluz De Salud | Vaccine against Acinetobacter baumannii based on lipopolysaccharide-deficient cellular components |
| GB201503812D0 (en) * | 2015-03-06 | 2015-04-22 | Univ Aberdeen | Antibody molecules and uses thereof |
| CN108472372B (zh) * | 2015-07-13 | 2022-05-17 | 海港医学中心洛杉矶生物医学研究所 | 结合不动杆菌的抗体结合剂及其用途 |
| EP3426287A4 (en) | 2016-03-09 | 2020-03-11 | Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
| GB201902769D0 (en) * | 2019-03-01 | 2019-04-17 | Univ Court Of The Univ Of Aberdeen | Antibody molcules and uses thereof |
| US20220354935A1 (en) * | 2021-04-21 | 2022-11-10 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | Vaccination against fungal epitopes to prevent inflammatory bowel diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150942A1 (en) * | 2008-12-03 | 2010-06-17 | Cantor Thomas L | Affinity purified human polyclonal antibodies and methods of making and using them |
| WO2011003085A1 (en) | 2009-07-03 | 2011-01-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Hyr1 as a target for active and passive immunization against candida |
-
2012
- 2012-09-14 BR BR112014005773-7A patent/BR112014005773A2/pt not_active IP Right Cessation
- 2012-09-14 GE GEAP201213226A patent/GEP20197052B/en unknown
- 2012-09-14 EP EP12832321.9A patent/EP2755668A4/en not_active Withdrawn
- 2012-09-14 JP JP2014530899A patent/JP2014527084A/ja active Pending
- 2012-09-14 US US14/344,838 patent/US10160790B2/en active Active
- 2012-09-14 UA UAA201310982A patent/UA115305C2/uk unknown
- 2012-09-14 GE GEAP201913226A patent/GEAP201913226A/en unknown
- 2012-09-14 AU AU2012308281A patent/AU2012308281A1/en not_active Abandoned
- 2012-09-14 CA CA2848403A patent/CA2848403A1/en not_active Abandoned
- 2012-09-14 WO PCT/US2012/055604 patent/WO2013040478A2/en not_active Ceased
- 2012-09-14 CN CN201280056018.2A patent/CN103998049A/zh active Pending
- 2012-09-14 EA EA201391199A patent/EA025831B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GEAP201913226A (en) | 2019-07-10 |
| UA115305C2 (uk) | 2017-10-25 |
| EP2755668A4 (en) | 2015-07-01 |
| CN103998049A (zh) | 2014-08-20 |
| WO2013040478A2 (en) | 2013-03-21 |
| US20150191514A1 (en) | 2015-07-09 |
| WO2013040478A3 (en) | 2013-06-27 |
| AU2012308281A1 (en) | 2014-04-24 |
| EA201391199A1 (ru) | 2014-04-30 |
| US10160790B2 (en) | 2018-12-25 |
| JP2014527084A (ja) | 2014-10-09 |
| CA2848403A1 (en) | 2013-03-21 |
| EA025831B1 (ru) | 2017-02-28 |
| EP2755668A2 (en) | 2014-07-23 |
| GEP20197052B (en) | 2019-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014005773A2 (pt) | composições derivadas de hyr1 e métodos of tratamento usando as mesmas | |
| CL2017002283A1 (es) | Formulaciones de anticuerpos y métodos (divisional de solicitud n°1081-2014) | |
| PE20161032A1 (es) | Anticuerpos anti-tau(ps422) humanizados y metodos de utilizacion | |
| AU2012249274A8 (en) | Neutralizing antibodies to Nipah and Hendra virus | |
| MX341076B (es) | Formulaciones estables de anticuerpos para el receptor humano pd-1 de meurte programada y tratamientos relacionados. | |
| HRP20180972T1 (hr) | Kombinacija fenoksibenzamina i polimiksina e za liječenje mikrobnih infekcija | |
| BR112013026929A2 (pt) | composição e método para intensificação de uma resposta imune | |
| EA201590388A1 (ru) | Способы лечения таупатии | |
| BR112013020425A2 (pt) | composições e métodos para o tratamento ou prevenção de infecção por vírus da hepatite b | |
| PH12015500724B1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| MX349886B (es) | Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas. | |
| MX2018000590A (es) | Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79). | |
| MX2014004326A (es) | Anticuerpos a cd1d. | |
| WO2013106689A8 (en) | Hcv ns3 protease inhibitors | |
| SG10201807059QA (en) | Agents for influenza neutralization | |
| GB201109238D0 (en) | Antibodies | |
| BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
| BR112015022963A8 (pt) | composições e métodos para tratar patógenos fúngicos e bacterianos. | |
| BR112015016033A2 (pt) | composições e métodos para tratamento de infecções por bactérias | |
| HK1209639A1 (en) | Gpbp-1 inhibition and its therapeutic use | |
| EA201691452A1 (ru) | Композиции для применения в лечении аллергических состояний | |
| WO2013067160A3 (en) | Anti-bacterial polypeptides and pathogen specific synthetic antibodies | |
| BR112013010926A2 (pt) | agentes imunomoduladores e seus usos | |
| BR112015031585A2 (pt) | composição farmacêutica | |
| BR112012029881A2 (pt) | combinação de anticorpos anti-envelope e anticorpos anti-receptor para o tratamento e a presenção de infecção por hcv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |